Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

198 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Feasibility study and methodology to create a quality-evaluated database of primary care data.
Bourke A, Dattani H, Robinson M. Bourke A, et al. Inform Prim Care. 2004;12(3):171-7. doi: 10.14236/jhi.v12i3.124. Inform Prim Care. 2004. PMID: 15606990
OBJECTIVES: To build and test a model for the collection of computerised retrospective primary care data from the UK, and to assess its quality for use in medical and pharmaceutical research. ...RESULTS: Initial audit of 236 practices indicated good recording of prescribin …
OBJECTIVES: To build and test a model for the collection of computerised retrospective primary care data from the UK, and to assess i …
The distribution of lung cancer across sectors of society in the United Kingdom: a study using national primary care data.
Iyen-Omofoman B, Hubbard RB, Smith CJ, Sparks E, Bradley E, Bourke A, Tata LJ. Iyen-Omofoman B, et al. BMC Public Health. 2011 Nov 10;11:857. doi: 10.1186/1471-2458-11-857. BMC Public Health. 2011. PMID: 22074413 Free PMC article.
Secondly, we explored the potential of a geo-demographic social marketing tool to facilitate disease ascertainment by using Experian's Mosaic Public Sector ™ classification, to identify detailed profiles of the sectors of society where lung cancer incidence was highest. .. …
Secondly, we explored the potential of a geo-demographic social marketing tool to facilitate disease ascertainment by using Experian' …
Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates.
Blak BT, Thompson M, Dattani H, Bourke A. Blak BT, et al. Inform Prim Care. 2011;19(4):251-5. doi: 10.14236/jhi.v19i4.820. Inform Prim Care. 2011. PMID: 22828580
This report describes the representativeness of The Health Improvement Network (THIN), a UK primary care database, of the UK population. ...
This report describes the representativeness of The Health Improvement Network (THIN), a UK primary care database, of the UK populati …
Evidence generation from healthcare databases: recommendations for managing change.
Bourke A, Bate A, Sauer BC, Brown JS, Hall GC. Bourke A, et al. Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):749-54. doi: 10.1002/pds.4004. Epub 2016 May 17. Pharmacoepidemiol Drug Saf. 2016. PMID: 27183900 Review.
There is an increasing reliance on databases of healthcare records for pharmacoepidemiology and other medical research, and such resources are often accessed over a long period of time so it is vital to consider the impact of changes in data, access methodology and the env …
There is an increasing reliance on databases of healthcare records for pharmacoepidemiology and other medical research, and such resources a …
Guidelines for good database selection and use in pharmacoepidemiology research.
Hall GC, Sauer B, Bourke A, Brown JS, Reynolds MW, LoCasale R. Hall GC, et al. Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):1-10. doi: 10.1002/pds.2229. Epub 2011 Nov 8. Pharmacoepidemiol Drug Saf. 2012. PMID: 22069180
This guidance is presented as a detailed text with a checklist for quick reference and covers six areas: selection of a database, use of multiple data resources, extraction and analysis of the study population, privacy and security, quality and validation pro …
This guidance is presented as a detailed text with a checklist for quick reference and covers six areas: selection of a
An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy.
Richardson JL, Stephens S, Thomas SHL, Jamry-Dziurla A, de Jong-van den Berg L, Zetstra-van der Woude P, Laursen M, Hliva V, Mt-Isa S, Bourke A, Dreyer NA, Blackburn SC. Richardson JL, et al. JMIR Public Health Surveill. 2016 Mar 18;2(1):e13. doi: 10.2196/publichealth.5366. eCollection 2016 Jan-Jun. JMIR Public Health Surveill. 2016. PMID: 27227148 Free PMC article.
METHODS: The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) pregnancy study is a non-interventional, prospective pilot study of self-reported medication use and obstetric outcomes provided by a cohort of pregna …
METHODS: The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) pregnancy study is a
Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy.
Dreyer NA, Blackburn SC, Mt-Isa S, Richardson JL, Thomas S, Laursen M, Zetstra-van der Woude P, Jamry-Dziurla A, Hliva V, Bourke A, de Jong-van den Berg L. Dreyer NA, et al. JMIR Public Health Surveill. 2015 Dec 22;1(2):e22. doi: 10.2196/publichealth.4939. eCollection 2015 Jul-Dec. JMIR Public Health Surveill. 2015. PMID: 27227140 Free PMC article.
BACKGROUND: Little is known about the effects of human fetal exposure when a new drug is authorized unless it was specifically developed for use in pregnancy. ...METHODS: To pilot direct-to-patient research for pharmacovigilance, we conducted a prospective, noninter …
BACKGROUND: Little is known about the effects of human fetal exposure when a new drug is authorized unless it was specifically develo …
Balancing the interests of patient data protection and medication safety monitoring in a public-private partnership.
Dreyer NA, Blackburn S, Hliva V, Mt-Isa S, Richardson J, Jamry-Dziurla A, Bourke A, Johnson R. Dreyer NA, et al. JMIR Med Inform. 2015 Apr 15;3(2):e18. doi: 10.2196/medinform.3937. JMIR Med Inform. 2015. PMID: 25881627 Free PMC article.
Obtaining data without the intervention of a health care provider represents an opportunity to expand understanding of the safety of medications used in difficult-to-study situations, like the first trimester of pregnancy when women may not present for medical care. ...Non …
Obtaining data without the intervention of a health care provider represents an opportunity to expand understanding of the safety of …
Smartphone- and Smartwatch-Based Remote Characterisation of Ambulation in Multiple Sclerosis during the Two-Minute Walk Test.
Creagh AP, Simillion C, Bourke A, Scotland A, Lipsmeier F, Bernasconi C, van Beek J, Baker M, Gossens C, Lindemann M, De Vos M. Creagh AP, et al. Among authors: bourke a. IEEE J Biomed Health Inform. 2020 May 28;PP. doi: 10.1109/JBHI.2020.2998187. Online ahead of print. IEEE J Biomed Health Inform. 2020. PMID: 32750915
198 results
Jump to page
Feedback